Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bisoprolol

bisoprolol

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of bisoprolol

10 trials tracked of bisoprolol: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 228 citations.

10Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 8 Phase 1 1 Other / NA 1
  1. Phase 4 Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Completed · 228 cited
  2. Phase 4 An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION]) Completed
  3. Phase 4 Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control Completed
  4. Phase 4 A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension Completed
  5. Phase 4 Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients Completed
  6. Phase 4 A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes Completed
Show 4 more trials
  1. Phase 4 Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients. Completed
  2. Phase 4 Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Completed
  3. Phase 1 Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants Completed
  4. N/A Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
Cardiology Meta-analysis
Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy Heart-Protecting Meds Show Promise for Cancer Patients
A meta-analysis of 19 RCTs in patients receiving anthracyclines and/or trastuzumab found beta-blockers improved LVEF (WMD=2.19) and reduced…
Two specific heart medications stand out as the most effective shields against heart damage caused by powerful cancer treatments.
Frontiers Apr 13, 2026